PPARGC1A and melanoma: Thus, BRAF and NRAS mutant melanomas contain a subpopulation of cells intrinsically resistant to MEK inhibitors, which displays a classic OXPHOS phenotype and PGC1α-dependent mitochondrial biogenesis [35].